Bavarian Nordic Rises As It Meets Demand For Monkeypox Vaccine
Shares Up 42% Following Unexplained Outbreaks
Executive Summary
The Danish company has the world’s only licensed monkeypox vaccine and is now fielding enquiries from concerned governments from around the world.
You may also be interested in...
Bavarian Nordic Deal Opens Up Potential China Market For RSV Vaccine
As three big players get set to reveal pivotal data for adult RSV vaccines, Bavarian Nordic seals a deal for its candidate that could still claim a sizeable niche if a late-stage trial delivers.
4D Pharma Is Latest Biotech Casualty After Creditor Calls Time
The UK biotech looks to have reached the end of the road, despite some encouraging signs from its microbiome-based pipeline.
Novartis To Cut 8,000 Jobs In Global Restructure
CEO Vas Narasimhan wants the company to be more agile and identify more blockbuster opportunities.